Understanding the impact of long-chain fatty acid oxidation disorders for patients and caregivers.

Authors:
Kruger E; Voorhees K; Thomas N; Judge M; Galla J and 2 more

Journal:
Mol Genet Metab Rep

Publication Year: 2022

DOI:
10.1016/j.ymgmr.2022.100903

PMCID:
PMC9421447

PMID:
36046395

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Genet Metab Rep

Abbreviation: Mol Genet Metab Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics & Heredity

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel <i>GATA3</i> frameshift mutation causes hypoparathyroidism, sensorineural deafness, and ren…
Huang B; Li S; Chai Y and 6 more (2024) - Transparency Score: 3/6
Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and G…
Guelbert N; Espitia Segura OM; Amoretti C and 32 more (2024) - Transparency Score: 3/6
Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactos…
Almenabawy N; Bahl S; Ostlund AL and 4 more (2024) - Transparency Score: 3/6
Induced pluripotent stem cell-derived hepatocytes reveal TCA cycle disruption and the potential bas…
Mathis D; Koch J; Koller S and 6 more (2024) - Transparency Score: 3/6
Letter to the Editors: Concerning "Hyperleucinosis during infections in maple syrup urine disease p…
Takano C; Ogawa E; Arai-Ichinoi N and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data sharing policy listed on ultragenyx com. acknowledgements kerri hebard-massey of ultragenyx pharmaceutical inc provided medical writing support. appendix a supplementary data to this article can be found online at https://doi"

Code Sharing
COI Disclosure
Evidence found in paper:

"Funding and disclosures ▪Funding for this research was provided by 10.13039/100013220Ultragenyx Pharmaceutical Inc.▪Ultragenyx Pharmaceutical Inc. participated in study design, analysis and interpretation of data, and writing the manuscript.▪Miller Judge, John Galla, Jeffrey Kung, and Diego Rodriguez are employees of Magnolia Innovation, which received payment from Ultragenyx Pharmaceutical Inc. for research analysis▪Eliza Kruger, Kristin Voorhees, and Nina Thomas are employees of Ultragenyx Pharmaceutical Inc."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025